Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > First USA Study Site

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jan 19, 2021 8:33am

137 Views

Post# 32324671

RE:RE:First USA Study Site

The non-evolution in the number of cases (14) since the last update simply reflects the reality of elective surgeries that have been postponed becasue of the COVID-19. Some hospitals are now activating their protocol where they have to choose between 2 patients, given the lack of places in ICUs.

<< Previous

Bullboard Posts

Next >>

Optimi Health makes commercial entry into Australia